Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1892 1
1968 2
1969 1
1980 1
1981 2
1983 1
1984 2
1985 1
1986 1
1987 2
1989 1
1990 3
1991 1
1992 1
1993 1
1994 1
1996 2
1997 1
1998 3
1999 3
2001 1
2002 2
2003 1
2004 1
2005 2
2006 3
2007 1
2008 3
2009 3
2010 4
2012 2
2013 1
2014 1
2015 3
2016 8
2017 3
2018 4
2019 3
2020 2
2021 2
2022 8
2023 3
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Choné L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, O'Callaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Conroy T, et al. Among authors: cripps c. N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775. N Engl J Med. 2018. PMID: 30575490 Clinical Trial.
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.
Conroy T, Castan F, Lopez A, Turpin A, Ben Abdelghani M, Wei AC, Mitry E, Biagi JJ, Evesque L, Artru P, Lecomte T, Assenat E, Bauguion L, Ychou M, Bouché O, Monard L, Lambert A, Hammel P; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Conroy T, et al. JAMA Oncol. 2022 Nov 1;8(11):1571-1578. doi: 10.1001/jamaoncol.2022.3829. JAMA Oncol. 2022. PMID: 36048453 Free PMC article. Clinical Trial.
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.
Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, Carter R, Tebbutt NC, Dervenis C, Smith D, Glimelius B, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Ghaneh P, Halloran CM, Lerch MM, Oláh A, Rawcliffe CL, Verbeke CS, Campbell F, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. JAMA. 2012 Jul 11;308(2):147-56. doi: 10.1001/jama.2012.7352. JAMA. 2012. PMID: 22782416 Clinical Trial.
Current Concepts in Maxillary Reconstruction.
Lee ZH, Cripps C, Rodriguez ED. Lee ZH, et al. Among authors: cripps c. Plast Reconstr Surg. 2022 Jul 1;150(1):168e-175e. doi: 10.1097/PRS.0000000000009195. Epub 2022 May 19. Plast Reconstr Surg. 2022. PMID: 35583953
Bariatric surgery in managing diabetes mellitus.
Roslin MS, Cripps CN. Roslin MS, et al. Among authors: cripps cn. Curr Opin Gastroenterol. 2016 Nov;32(6):481-486. doi: 10.1097/MOG.0000000000000312. Curr Opin Gastroenterol. 2016. PMID: 27607341 Review.
Fire as a driver of fungal diversity - A synthesis of current knowledge.
Fox S, Sikes BA, Brown SP, Cripps CL, Glassman SI, Hughes K, Semenova-Nelsen T, Jumpponen A. Fox S, et al. Among authors: cripps cl. Mycologia. 2022 Mar-Apr;114(2):215-241. doi: 10.1080/00275514.2021.2024422. Epub 2022 Mar 28. Mycologia. 2022. PMID: 35344467 Review.
87 results